Press "Enter" to skip to content

Tag: inflation

Season 3, Episode 1: The Biden Administration and Risks to Global Growth

With Barry Knapp, Ironsides Macroeconomics

This episode is brought to you by Merk Research. Visit this link to take advantage of the offer presented on the podcast. To listen without ads or announcements, become a premium subscriber.

Barry Knapp of Ironsides Macroeconomics rejoins the podcast to discuss his view on “policy tremors” that could upend economic and risk asset growth in 2021.

(Barry’s dog Oliver makes a brief appearance as well).

Content
(Spotify users can skip directly to the segment by clicking on the timestamp)
  • The current reflation theme is part of a recovery from what was actually a two-year recession in global manufacturing, trade, and capital spending (4:19);
  • The Federal Reserve will initially be pleased with rising inflation, having slayed the deflation boogeyman. This will eventually morph into discomfort (first from regional bank presidents) and concerns that inflation is moving “too far, too fast” (11:43);
  • Once this happens, Fed officials will begin discussing “policy normalization” and real rates will start to move, triggering a risk-off event (13:19);
  • The Georgia elections the first week of the year were a kind of “sneak preview” of this event, but look to mid-year for the real McCoy (16:37);
  • Another important indicator: Watch house prices through the spring selling season (20:40);
  • Two details of President-elect Biden’s $1.9 trillion stimulus proposal that are not fully appreciated by the market (21:41);
  • The Democrats will likely ask for more than Republicans are willing to give, triggering reconciliation that would be a rude awakening for the market (28:38);
  • If the $1400 stimulus checks go through it may lead to another “speculative blow off” (30:50);
  • There is no indication President-elect Biden is willing to roll back tariffs on China, though he could re-engage in TPP. But anybody expecting a broader unwinding of the trade war “is pretty off-base” (33:00);
  • Look for further USD weakness, particularly against the yen and the euro (37:57);
  • Favorite asset classes for 2021 (41:09)
More About The Guest
Not intended as investment advice.
Comments closed

Season 2, Episode 30: The Real ‘Melt-Up Is Still Ahead of Us’

September was a “fake out sell off,” says David Hunter.

David Hunter of Contrarian Macro Advisors rejoins the podcast to update listeners on his vision of a “parabolic melt-up” in risk assets that will presage the next market crash.

What we’ve seen since late March was not the real melt-up, Hunter says. Most of the gains are still ahead, in fact the coming months should see the final (and most dramatic) period of the rally. Then things get ugly.

Leave a Comment

Season 2, Episode 15: Healthcare, Tech Stocks May Not Be As Defensive As Believed

With Chris Brown of Aristides Capital

Christopher Brown of Aristides Capital joins the podcast to discuss his investment strategy, which has produced positive returns every calendar year since 2008.

Update: This podcast episode has been transcribed! Read it here.

In Brown’s view, healthcare and information technology stocks should not be treated as defensive investments that will protect portfolios in times of stress — especially after their recent run-up. There are reasons many companies in this sector are overvalued and could see their shares drop as the economy begins to see further difficulties from coronavirus.

Aristides Capital has an active short book, which framed most of the second half of the conversation.  

Content Segments: 

  • Why investors’ thinking about defensive stocks may be misguided (4:49)
  • Growth stocks’ recent performance is reminiscent of the late-1990s tech bubble (7:05)
  • The concerns with healthcare stocks (11:45)
  • Background on the guest (15:07)
  • Some of the red flags short sellers look for and why the “big picture” is often more pertinent (20:22)
  • Inovio Pharmaceuticals (NASDAQ: INO) discussion (22:52)
  • CytoDyn Inc. (OTC: CYDY) discussion (25:44)
  • Vuzix Corp. (NASDAQ: VUZI) discussion (28:37)
  • Accelerate Diagnostics (NASDAQ: AXDX) discussion (30:59)
  • Insider purchases are not always a bullish indicator (35:02)
  • Tesla Inc. (NASDAQ: TSLA) discussion, at the guest’s suggestion (host didn’t want to go there originally) and why it could be an indicator for future market direction (36:17)
  • Reasons to be bearish on markets and the economy (39:17)
  • How to protect your portfolio against inflation (42:13)

Quick Highlights From Our YouTube Channel

For more information on the guest:

Not intended as investment advice.

Leave a Comment